Multispan

Multispan

Biotechnology company engaged in drug discovery research focused on g protein-coupled receptors (gpcrs). Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-

$500k

Series A

$600k

Series B
Total Funding$1.1m

Recent News about Multispan

Edit
More about Multispaninfo icon
Edit

Multispan, Inc. is a leading company specializing in cell engineering assay screening, primarily focusing on cellular drug discovery research targeting G-protein-coupled receptors (GPCRs). The company serves pharmaceutical and biotechnology clients who are engaged in drug discovery and development. Operating in the highly specialized market of cellular assays, Multispan provides highly characterized cell lines, membranes, and kits tailored for GPCR research. Their business model revolves around offering both off-the-shelf and custom-engineered cell solutions, as well as providing screening services for secondary compound profiling. Multispan generates revenue through the sale of their proprietary cell lines and membranes, as well as through service contracts for custom cell engineering and screening services. The company is known for its rapid turnaround time, delivering screening and profiling results within just a few days, which is a significant advantage in the fast-paced drug discovery industry.

Keywords: GPCR, cell engineering, assay screening, drug discovery, biotechnology, pharmaceutical, custom cells, profiling services, rapid results, cellular assays.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.